Synthesis of tacrine derivatives under solventless conditions

Journal of Heterocyclic Chemistry

Volumn 44, Issue 3, 2007, Pages 535-538

  Khalilzadeh, Mohammad A ^a   Hosseini, Abolfazl ^a   Tajbakhsh', Mahmoud ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRANILONITRILE DERIVATIVE; CYCLOHEXANONE; NITRILE; TACRINE; TACRINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; MICROWAVE IRRADIATION; REACTION ANALYSIS; SOLID PHASE SYNTHESIS;

EID: 38949150895     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570440305     Document Type: Article

References (49)

1. [a] Wurtman, R. J. Alzheimer's disease. Sci. Am. 1985, 252, 48-56;
2. [b] Alzheimer's Diseases Problems, Prospects and Perspectives; Altman, H. J. Ed., Plenum Press, New York, 1987.
3. [a] Davies, P.; Maloney, A. J. F. Lancet. 1976, 2, 1403-1404;
4. [b] Bowen, D. M.; Smith, C. B.; White, P.; Dawson, A. N. Brain. 1976, 99, 459-496.
5. Iversen, L. L.; Rossor, M. Br. Med. Bull. 1986, 42, 70-74.
6. Perry, E. K. Br. Med. Bull. 1986, 42, 63-69.
7. Wesseling, A.; Agoston, S. N. Engl. J. Med. 1988, 310, 988-989.
8. [a] Mohs, R. C.; Davis, K. L. The experimental pharmacology of Alzheimer's disease and related dementias. In Psychopharmacology: The Third Generation of Progress; Meltzer, H. Y. Ed., Raven Press, New York, 1987;
9. [b] Signoret, J. L.; Whitely A.; Lhermitte, F. Lancet. 1978, 2, 837-841;
10. [c] Cohen E. I.; Wurtman, R. J. Science 1976, 191, 561-562;
11. [d] Hanbrich, D. R.; Wang, P. F. L.; Clody, D. E.; Wedeking, P. W. Life Sci. 1975, 17, 975-980.
12. Summers, W. K.; Majovski, L. V.; Marsh, G. M.; Tachiki K.; Kling, A.; N. Engl. J. Med. 1986, 315, 1241-1245.
13. Albert A.; Gledhill, W. J. J. Soc. Chem. Ind. 1945, 64, 169-172.
14. Shaw F. H.; Bentley, G. Aust. J. Exp. Biol. Med. Sci. 1953, 31, 573-576.
15. Heilbronn, E. Acta Chem. Scand. 1961, 15, 1386-1390.
16. Maayani, S.; Weinstein, H.; Ben-Zvi, N.; Cohen, S.; Sokolovsky, M. Biochem. Pharmacol. 1974, 23, 1263-1281.
17. Harvey A. L.; Rowan, E. G. Action of THA, 3,4-diaminopyridine, physostigmine and galanthamine on neuronal K+ currents at a cholinergic nerve terminal. Current Research in Alzheimer Therapy, Giacobini, E. Becker, R.; Ed., Taylor and Francis, New York, pp 191-197.
18. [a] Drukarch, B.; Leysen J. E.; Stoof, J. C. Life Sci. 1988, 42, 1011-1017;
19. [b] Sokhwinder, J.; Adem, A.; Winblad B.; Oreland, L. Pharmacol. Toxicol. 1992, 71, 213-215.
20. [a] Kaul, P. N. J. Pharm. Pharmacol. 1962, 14, 243-248;
21. (b) Neilsen, J. A.; Mena, E. E.; Williams, I. H.; Nocerini M. R.; Liston, D. Eur. J. Pharmacol. 1988, 173, 53-64;
22. [c] McNally, W.; Rothom, R.; Young, Brockbrader, H.; Chang, T. Pharm. Res. 1989, 924-930.
23. [a] Moore, J. A.; Karnreich, L. D. Tetrahedron Lett. 1963, 20, 1277-1281;
24. [b] Lee T. B. K.; Goehring, K. E. Us Patent 5155226, Chem. Abstr. 1992, 117, P233875p;
25. [c] Sujan, S.; Meyers, A. I. J. Heterocyclic chem. 1968, 737;
26. [d] Mekenna, M. T.; Proctor, G. R.; Young L. C.; Harveg, A. L. J. Med. Chem. 1997, 40, 3516;
27. [e] Girgis, N. S.; Pedersen, E. B. Synthesis 1985, 547;
28. [f] Angeles, M-G.; JoséL, M. Bioorg. Med. Chem. Lett. 1997, 7, 3165-3170.
29. [a] Kingston H. M.; Haswell, S. J. Microwave-Enhanced Chemistry fundamentals, Sample Preparation and Applications. Ed., American Chemical Society, Washington, D.C. 1997;
30. [b] For reviews, see: Perreux, L. and Loupy, A. Tetrahedron 2001, 57, 9199-9223;
31. [c] Lindstroem, P.; Tierney, J.; Whathey B.; Westman, J. Tetrahedron 2001, 57, 9225-9283.
32. [a] Tanaka, K.; Toda, F. Chem. Rev. 2000, 100, 1025-1074;
33. [b] Loupy, A. Topic curr. Chem. 1999, 206, 153-208;
34. [c] Metzger, J. O. Angew. Chem. Int. Ed. Engl. 1998, 37, 2975-2978.
35. Anastas, P.T.; Warner, C. Green Chemistry, Theory and Practice, Oxford, 1998.
36. [a] Cave G. W. V.; Raston, C. L. Chem. Commun. 2000, 2199-2200;
37. [b] Loh, T. P.; Huang, J. M.; Goh S. H.; Vittal, J. J. Org. Lett. 2000, 2, 1291-1294;
38. [c] Miyamato, H.; Kanetaka, S.; Tanaka, K.; Yoshizawa, K.; Toyota S.; Toda, F. Chem. Lett. 2000, 8, 888-889.
39. [d] Sato, I.; Saito T.; Soai, K. Chem. Commun. 2000, 2471-2472;
40. [e] Kalbalka, G. W.; Wang, L.; Namnoodiri, V.; Pagni, R. M. Tetrahedron Lett. 2000, 41, 5151-5154;
41. [f] Larhed, M.; Lindeberg G.; Hallberg, A. Tetrahedron Lett. 1996, 37, 8219-8222;
42. [g] Dalton J. R.; Regen, S. L. J. Org. Chem. 1979, 44, 4443-4444;
43. [h] Villemin D.; Caillot, F. Tetrahedron Lett. 2001, 42, 639-642.
44. Bielavsky, J. Czech. Patent 181474, Chem. Abstr. 1980, 93, 204471j.
45. Recanatini, M.; Cavalli, A.; Beilud, F.; Piazzi, L.; Rampa, A.; Bisi, A.; Gobbi, S.; Valenti, P.; Andrisano, V.; Bartolini M.; Cavrini, V. J. Med. Chem. 2000, 43, 2007-2018.
46. Gregor, V. E.; Emmerling, M. R.; Lee C.; Moore, C. J. Bioorg. Med. Chem. Lett. 1992, 2, 861-864.
47. Pirrung, M. C.; Chau J. H.-L.; Chen, J. Chem. Biol. 1995, 2, 621-626.
48. Del Giudice, M. R.; Borioni, A.; Mustazza, C.; Gatta, F.; Meneguz A.; Volpe, M. T. Farmaco. 1996, 51, 693-698.
49. Kawakami, H.; Ohuchi, R.; Kitano M.; Ono, K. Eur. Patent 268871, Chem. Abstr. 1988, 109, 110275v.